M, R., A, M., A, B., F, D. C., G, V., C, A., . . . LF, I. (2025). Pharmacological differences and switching among anti-CGRP monoclonal antibodies: A narrative review. Headache, 65(2), 342. https://doi.org/10.1111/head.14903
Chicago Style (17th ed.) CitationM, Romozzi, et al. "Pharmacological Differences and Switching Among Anti-CGRP Monoclonal Antibodies: A Narrative Review." Headache 65, no. 2 (2025): 342. https://doi.org/10.1111/head.14903.
MLA (9th ed.) CitationM, Romozzi, et al. "Pharmacological Differences and Switching Among Anti-CGRP Monoclonal Antibodies: A Narrative Review." Headache, vol. 65, no. 2, 2025, p. 342, https://doi.org/10.1111/head.14903.
Warning: These citations may not always be 100% accurate.